Beyond Compliance: How Sponsors Can Drive Success with Central eSource at Investigator Sites

Beyond Compliance: How Sponsors Can Drive Success with Central eSource at Investigator Sites

Running efficient, high-quality clinical trials is paramount in drug development. Too often, sponsors and CROs face opposition when evaluating tools that defy the status quo, thinking that regulatory guidance does not support novel and innovative methods in clinical research.

Luckily, your experts from CRIO have scrutinized relevant regulations and guidelines to debunk just that.

We’ve analyzed ICH E6(R3), ICH E8(R1), and 21 CFR 312 to provide the reader with a clear understanding on how these regulations align with the central electronic source (eSource) approach. Central eSource is the concept of providing clinical research sites with centrally developed protocol driven eSource forms to ensure consistent and compliant data collection that also enables centralized monitoring and better sponsor oversight, while at the same time reducing site burden.

Please register below for access to this online resource.

Beyond Compliance
By downloading this content, you agree to MJH Life Sciences® Terms and Conditions, Privacy Policy, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you may be interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact info@mjhassoc.com.